Publication: 3228

Publication: 3228

Celecoxib in addition to standard adjuvant therapy with 5-fluorouracil, leucovorin, oxaliplatin (FOLFOX) in stage III colon cancer: Results from CALGB/SWOG 80702

DOI

URL

Google Scholar

Citation:: JCO vol 38 (no. 15_suppl) 4003

Meeting Instance:: ASCO 2020
Year:: 2020
Type:: Abstract
Sub type:: Oral
Funding:: NCTN
Endpoint:: Primary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: epub

Note:

Methodological:: No
Biospecimen:: No
SDC:: No

Parents:: None
Children:: 3430

Program:: OGC
Primary Committee:: GI
Sec. Committees:

Pharmas:: Pfizer
Grants:: U10CA180821, U10CA180882; U10CA180863 (CCTG); UG1CA233196, U10CA180820 (ECOG-ACRIN); U10CA180868 (NRG); U10CA180888 (SWOG);

Corr. Author:
Authors:: Jeffrey A. Meyerhardt Qian Shi Charles S. Fuchs Donna Niedzwiecki Tyler Zemla Priya Kumthekar Katherine A. Guthrie Felix Couture Philip Kuebler Johanna C. Bendell Pankaj Kumar Dequincy Lewis Benjamin Tan Monica Bertagnolli Axel Grothey Howard S. Hochster Richard M. Goldberg Alan Venook Charles Blanke Anthony F. Shields

Networks:: CA824, HEARTLAND, LAPS-CT018, LAPS-IL036, LAPS-MA036, LAPS-MN026, LAPS-MO011, LAPS-OH007, OR013, SCOR

Study: CALGB-80702
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 3

Keywords: